advertisement
11.1 General management, indication (23)
Showing records 1 to 23
Display all abstracts in classification 11.1 General management, indication
Search within classification 11.1 General management, indication84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Occhiutto ML
Advances in Therapy 2020; 37: 155-199
84463 Treatment choices for newly diagnosed primary open angle and ocular hypertension patients
Garg A
Eye 2020; 34: 60-71
84465 10-year trends in English primary care glaucoma prescribing
Hogg HDJ
Eye 2020; 34: 192-196
84667 Systematic reviews and randomised controlled trials on open angle glaucoma
Wormald R
Eye 2020; 34: 161-167
84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Parkkari M
Acta Ophthalmologica 2019; 0:
84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Yu L
PLoS ONE 2020; 15: e0227595
85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
King AJ
American Journal of Ophthalmology 2020; 213: 186-194
84615 Secondary Neuroprotection in Glaucoma by Reduction of Intraocular Pressure
Unterlauft JD
Klinische Monatsblätter für Augenheilkunde 2020; 237: 150-157
84667 Systematic reviews and randomised controlled trials on open angle glaucoma
Virgili G
Eye 2020; 34: 161-167
84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Taipale J
Acta Ophthalmologica 2019; 0:
85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Hudson J
American Journal of Ophthalmology 2020; 213: 186-194
84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Maranhão RC
Advances in Therapy 2020; 37: 155-199
84465 10-year trends in English primary care glaucoma prescribing
Connor A
Eye 2020; 34: 192-196
84463 Treatment choices for newly diagnosed primary open angle and ocular hypertension patients
Gazzard G
Eye 2020; 34: 60-71
84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Ding K; Luo L
PLoS ONE 2020; 15: e0227595
85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Fernie G
American Journal of Ophthalmology 2020; 213: 186-194
84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Costa VP
Advances in Therapy 2020; 37: 155-199
84667 Systematic reviews and randomised controlled trials on open angle glaucoma
Azuara-Blanco A
Eye 2020; 34: 161-167
84831 Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland
Uusitalo H
Acta Ophthalmologica 2019; 0:
84920 Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017
Yu Z
PLoS ONE 2020; 15: e0227595
85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Burr J
American Journal of Ophthalmology 2020; 213: 186-194
84728 Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review
Konstas AG
Advances in Therapy 2020; 37: 155-199
85065 Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial
Azuara-Blanco A; Sparrow J; Barton K; Garway-Heath DF; Kernohan A; Maclennan G;
American Journal of Ophthalmology 2020; 213: 186-194